APO Research
Talk to an analyst

APO RESEARCH · REPORT

HPV Testing

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

Selected research

Market Outlook & Growth Opportunities

Global HPV Testing Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchHPV Testing Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal HPV Testing Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal HPV Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HPV Testing Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal HPV Testing Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

Global HPV Testing key players include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, etc. Global top five players hold a share about 80%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.

Read the full market overview

In terms of product, Co-testing is the largest segment, with a share about 55%. And in terms of application, the largest application is Cervical Cancer Screening, followed by Vaginal Cancer Screening, etc.

This report provides an overview of the global HPV Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HPV Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HPV Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global HPV Testing market.

HPV Testing Segment by Company

Qiagen

Roche Diagnostics

Hologic

Abbott Laboratories

BD

Seegene, Inc.

HPV Testing Segment by Type

HPV Testing

Follow-up HPV Testing

Co-testing

HPV Testing Segment by Application

Cervical Cancer Screening

Vaginal Cancer Screening

Other

HPV Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global HPV Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the HPV Testing key companies, revenue, market share, and recent developments.

3. To split the HPV Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions HPV Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify HPV Testing significant trends, drivers, influence factors in global and regions.

6. To analyze HPV Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HPV Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HPV Testing industry.

Chapter 3: Detailed analysis of HPV Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of HPV Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of HPV Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. HPV Testing Industry Trends Table 2. HPV Testing Industry Drivers Table 3. HPV Testing Industry Opportunities and Challenges Table 4. HPV Testing Industry Restraints Table 5. Global HPV Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global HPV Testing Revenue Share by Company (2021-2026) Table 7. Global HPV Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global HPV Testing Key Company Manufacturing Base & Headquarters Table 9. Global HPV Testing Company, Product Type & Application Table 10. Global HPV Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global HPV Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of HPV Testing Table 15. Significant Companies of Follow-up HPV Testing Table 16. Significant Companies of Co-testing Table 17. Global HPV Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global HPV Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global HPV Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global HPV Testing Sales Value Share by Type (2021-2026) Table 21. Global HPV Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Cervical Cancer Screening Table 23. Significant Companies of Vaginal Cancer Screening Table 24. Significant Companies of Other Table 25. Global HPV Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global HPV Testing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global HPV Testing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global HPV Testing Sales Value Share by Application (2021-2026) Table 29. Global HPV Testing Sales Value Share by Application (2027-2032) Table 30. Global HPV Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global HPV Testing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global HPV Testing Sales Value Share by Region (2021-2026) Table 33. Global HPV Testing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global HPV Testing Sales Value Share by Region (2027-2032) Table 35. Global HPV Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global HPV Testing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global HPV Testing Sales Value Market Share by Country (2021-2026) Table 38. Global HPV Testing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global HPV Testing Sales Value Market Share by Country (2027-2032) Table 40. Qiagen Company Information Table 41. Qiagen Business Overview Table 42. Qiagen HPV Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Qiagen HPV Testing Product Portfolio Table 44. Qiagen Recent Development Table 45. Roche Diagnostics Company Information Table 46. Roche Diagnostics Business Overview Table 47. Roche Diagnostics HPV Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Roche Diagnostics HPV Testing Product Portfolio Table 49. Roche Diagnostics Recent Development Table 50. Hologic Company Information Table 51. Hologic Business Overview Table 52. Hologic HPV Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Hologic HPV Testing Product Portfolio Table 54. Hologic Recent Development Table 55. Abbott Laboratories Company Information Table 56. Abbott Laboratories Business Overview Table 57. Abbott Laboratories HPV Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Abbott Laboratories HPV Testing Product Portfolio Table 59. Abbott Laboratories Recent Development Table 60. BD Company Information Table 61. BD Business Overview Table 62. BD HPV Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. BD HPV Testing Product Portfolio Table 64. BD Recent Development Table 65. Seegene, Inc. Company Information Table 66. Seegene, Inc. Business Overview Table 67. Seegene, Inc. HPV Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Seegene, Inc. HPV Testing Product Portfolio Table 69. Seegene, Inc. Recent Development Table 70. Research Programs/Design for This Report Table 71. Authors List of This Report Table 72. Secondary Sources Table 73. Primary Sources List of Figures Figure 1. HPV Testing Product Image Figure 2. Global HPV Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HPV Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global HPV Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. HPV Testing Image Figure 8. Follow-up HPV Testing Image Figure 9. Co-testing Image Figure 10. Global HPV Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global HPV Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global HPV Testing Sales Value Share by Type (2021-2032) Figure 13. Cervical Cancer Screening Image Figure 14. Vaginal Cancer Screening Image Figure 15. Other Image Figure 16. Global HPV Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global HPV Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global HPV Testing Sales Value Share by Application (2021-2032) Figure 19. Global HPV Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global HPV Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America HPV Testing Sales Value (2021-2032) & (US$ Million) Figure 22. North America HPV Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe HPV Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe HPV Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific HPV Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific HPV Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America HPV Testing Sales Value (2021-2032) & (US$ Million) Figure 28. South America HPV Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa HPV Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa HPV Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt HPV Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt HPV Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt HPV Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • HPV Testing
  • Follow-up HPV Testing
  • Co-testing
Applications
  • Cervical Cancer Screening
  • Vaginal Cancer Screening
  • Other
Companies covered
  • Qiagen
  • Roche Diagnostics
  • Hologic
  • Abbott Laboratories
  • BD
  • Seegene, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global HPV Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global HPV Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 HPV Testing Market Dynamics
  1. 2.1 HPV Testing Industry Trends
  2. 2.2 HPV Testing Industry Drivers
  3. 2.3 HPV Testing Industry Opportunities and Challenges
  4. 2.4 HPV Testing Industry Restraints
3 HPV Testing Market by Company
  1. 3.1 Global HPV Testing Company Revenue Ranking in 2025
  2. 3.2 Global HPV Testing Revenue by Company (2021-2026)
  3. 3.3 Global HPV Testing Company Ranking (2024-2026)
  4. 3.4 Global HPV Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global HPV Testing Company Product Type and Application
  6. 3.6 Global HPV Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global HPV Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 HPV Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 HPV Testing Market by Type
  1. 4.1 HPV Testing Type Introduction
  2. 4.1.1 HPV Testing
  3. 4.1.2 Follow-up HPV Testing
  4. 4.1.3 Co-testing
  5. 4.2 Global HPV Testing Sales Value by Type
  6. 4.2.1 Global HPV Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global HPV Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global HPV Testing Sales Value Share by Type (2021-2032)
5 HPV Testing Market by Application
  1. 5.1 HPV Testing Application Introduction
  2. 5.1.1 Cervical Cancer Screening
  3. 5.1.2 Vaginal Cancer Screening
  4. 5.1.3 Other
  5. 5.2 Global HPV Testing Sales Value by Application
  6. 5.2.1 Global HPV Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global HPV Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global HPV Testing Sales Value Share by Application (2021-2032)
6 HPV Testing Regional Value Analysis
  1. 6.1 Global HPV Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global HPV Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global HPV Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global HPV Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America HPV Testing Sales Value (2021-2032)
  7. 6.3.2 North America HPV Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe HPV Testing Sales Value (2021-2032)
  10. 6.4.2 Europe HPV Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific HPV Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific HPV Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America HPV Testing Sales Value (2021-2032)
  16. 6.6.2 South America HPV Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa HPV Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa HPV Testing Sales Value Share by Country, 2025 VS 2032
7 HPV Testing Country-level Value Analysis
  1. 7.1 Global HPV Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global HPV Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global HPV Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global HPV Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA HPV Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA HPV Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA HPV Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada HPV Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada HPV Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada HPV Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico HPV Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico HPV Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico HPV Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany HPV Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany HPV Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany HPV Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France HPV Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France HPV Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France HPV Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. HPV Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. HPV Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. HPV Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy HPV Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy HPV Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy HPV Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain HPV Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain HPV Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain HPV Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia HPV Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia HPV Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia HPV Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands HPV Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands HPV Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands HPV Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries HPV Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries HPV Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries HPV Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China HPV Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China HPV Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China HPV Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan HPV Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan HPV Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan HPV Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea HPV Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea HPV Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea HPV Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India HPV Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India HPV Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India HPV Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia HPV Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia HPV Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia HPV Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia HPV Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia HPV Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia HPV Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil HPV Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil HPV Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil HPV Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina HPV Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina HPV Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina HPV Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile HPV Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile HPV Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile HPV Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia HPV Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia HPV Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia HPV Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru HPV Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru HPV Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru HPV Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia HPV Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia HPV Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia HPV Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel HPV Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel HPV Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel HPV Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE HPV Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE HPV Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE HPV Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey HPV Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey HPV Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey HPV Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran HPV Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran HPV Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran HPV Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt HPV Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt HPV Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt HPV Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Qiagen
  2. 8.1.1 Qiagen Company Information
  3. 8.1.2 Qiagen Business Overview
  4. 8.1.3 Qiagen HPV Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Qiagen HPV Testing Product Portfolio
  6. 8.1.5 Qiagen Recent Developments
  7. 8.2 Roche Diagnostics
  8. 8.2.1 Roche Diagnostics Company Information
  9. 8.2.2 Roche Diagnostics Business Overview
  10. 8.2.3 Roche Diagnostics HPV Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Diagnostics HPV Testing Product Portfolio
  12. 8.2.5 Roche Diagnostics Recent Developments
  13. 8.3 Hologic
  14. 8.3.1 Hologic Company Information
  15. 8.3.2 Hologic Business Overview
  16. 8.3.3 Hologic HPV Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hologic HPV Testing Product Portfolio
  18. 8.3.5 Hologic Recent Developments
  19. 8.4 Abbott Laboratories
  20. 8.4.1 Abbott Laboratories Company Information
  21. 8.4.2 Abbott Laboratories Business Overview
  22. 8.4.3 Abbott Laboratories HPV Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Laboratories HPV Testing Product Portfolio
  24. 8.4.5 Abbott Laboratories Recent Developments
  25. 8.5 BD
  26. 8.5.1 BD Company Information
  27. 8.5.2 BD Business Overview
  28. 8.5.3 BD HPV Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BD HPV Testing Product Portfolio
  30. 8.5.5 BD Recent Developments
  31. 8.6 Seegene, Inc.
  32. 8.6.1 Seegene, Inc. Company Information
  33. 8.6.2 Seegene, Inc. Business Overview
  34. 8.6.3 Seegene, Inc. HPV Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Seegene, Inc. HPV Testing Product Portfolio
  36. 8.6.5 Seegene, Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst